Product Code: PM2586
The global Genetic Toxicology Testing Market size is expected to reach USD 3.21 billion by 2030, according to a new study by Polaris Market Research. The report "Genetic Toxicology Testing Market Share, Size, Trends, Industry Analysis Report, By Type (In Vitro, In Vivo), By Product (Services, Reagents & Consumables); By Application (Cosmetic Industry, Healthcare Industry); By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides an analysis of future market growth.
Genetic toxicology testing is an in-depth study of the pharmaceutical and biotechnology sector where harmful substances are detected in the body and removed. Furthermore, increasing R&D and pharmaceutical activities and opposing animal testing are the factors that contribute to the industry's growth.
In addition, the growing geriatric population across nations such as India, Japan, Brazil, Mexico, and China are likely to positively impact the demand for genetic toxicology testing over the forecast period. Many government initiatives and investments increased the development activities in the pharmaceutical sector.
The market was positively impacted during the COVID-19 pandemic owing to the increasing test of SARS-CoV-2. FDA approved many toxicology kits during COVID-19 emergencies, such as in vitro toxicology assays and consumables. With COVID-19, there was an increase in profiling studies, COVID-19 testing, and healthcare awareness among people.
Genetic Toxicology Testing Market Report Highlights
In vitro and In vivo are anticipated to grow their sector in the market owing to the increasing focus on personalized medicines and drugs.
The service segment accounted for the highest revenue share in 2021 and is expected to continue its dominance owing to rising R&D activities in the pharmaceutical sector and increasing interest in omics studies.
The cosmetic industry is expected to grow during the forecast period owing to the higher consumption of cosmetic products by the people.
Asia Pacific is expected to grow at a significant CAGR over the forecast period on account of increasing government investment, R&D advancement, and technological advancements in the region, such as in India and China.
Major players operating in the industry include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Eurofins Scientific, Merck KGAA, Jubilant Life Sciences Ltd, Laboratory Corp of America Holdings, Gentronix Ltd, Creative Bioarray.
Polaris Market Research has segmented the genetic toxicology testing market report based on type, product, application, and region:
Genetic Toxicology Testing, Type Outlook (Revenue - USD Billion, 2018 - 2030)
In Vitro
In Vivo
Genetic Toxicology Testing, Product Outlook (Revenue - USD Billion, 2018 - 2030)
Reagents & Consumables
Assays
Services
Genetic Toxicology Testing, Application Outlook (Revenue - USD Billion, 2018 - 2030)
Healthcare Industry
Food Industry
Cosmetics Industry
Agriculture Industry
Others
Genetic Toxicology Testing, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Genetic Toxicology Testing Market Insights
- 4.1. Genetic Toxicology Testing - Industry Snapshot
- 4.2. Genetic Toxicology Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased number of pharmaceutical R&D activities
- 4.2.1.2. Risen global demand for humanized animal models
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Reluctance of countries toward replacement of in vivo methods with alternative testing
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Genetic Toxicology Testing Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Genetic Toxicology Testing Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 5.3. In vitro
- 5.3.1. Global Genetic Toxicology Testing Market, by In vitro, by Region, 2018 - 2030 (USD Billion)
- 5.4. In vivo
- 5.4.1. Global Genetic Toxicology Testing Market, by In vivo, by Region, 2018 - 2030 (USD Billion)
6. Global Genetic Toxicology Testing Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 6.3. Reagents & Consumables
- 6.3.1. Global Genetic Toxicology Testing Market, by Reagents & Consumables, by Region, 2018 - 2030 (USD Billion)
- 6.4. Assays
- 6.4.1. Global Genetic Toxicology Testing Market, by Assays, by Region, 2018 - 2030 (USD Billion)
- 6.5. Services
- 6.5.1. Global Genetic Toxicology Testing Market, by Services, by Region, 2018 - 2030 (USD Billion)
7. Global Genetic Toxicology Testing Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 7.3. Healthcare Industry
- 7.3.1. Global Genetic Toxicology Testing Market, by Hospitals Industry, by Region, 2018 - 2030 (USD Billion)
- 7.4. Food Industry
- 7.4.1. Global Genetic Toxicology Testing Market, by Food Industry, by Region, 2018 - 2030 (USD Billion)
- 7.5. Cosmetics Industry
- 7.5.1. Global Genetic Toxicology Testing Market, by Cosmetics Industry, by Region, 2018 - 2030 (USD Billion)
- 7.6. Agriculture Industry
- 7.6.1. Global Genetic Toxicology Testing Market, by Agriculture Industry, by Region, 2018 - 2030 (USD Billion)
- 7.7. Others
- 7.7.1. Global Other Genetic Toxicology Testing Market, by Region, 2018 - 2030 (USD Billion)
8. Global Genetic Toxicology Testing Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Genetic Toxicology Testing Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 8.3. Genetic Toxicology Testing Market - North America
- 8.3.1. North America: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.3.2. North America: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.3.3. North America: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.3.4. Genetic Toxicology Testing Market - U.S.
- 8.3.4.1. U.S.: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.3.4.2. U.S.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.3.4.3. U.S.: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.3.5. Genetic Toxicology Testing Market - Canada
- 8.3.5.1. Canada: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.3.5.2. Canada.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.3.5.3. Canada: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4. Genetic Toxicology Testing Market - Europe
- 8.4.1. Europe: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.2. Europe.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.3. Europe: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.4. Genetic Toxicology Testing Market - UK
- 8.4.4.1. UK: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.4.2. UK.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.4.3. UK: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.5. Genetic Toxicology Testing Market - France
- 8.4.5.1. France: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.5.2. France.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.5.3. France: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.6. Genetic Toxicology Testing Market - Germany
- 8.4.6.1. Germany: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.6.2. Germany.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.6.3. Germany: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.7. Genetic Toxicology Testing Market - Italy
- 8.4.7.1. Italy: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.7.2. Italy.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.7.3. Italy: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.8. Genetic Toxicology Testing Market - Spain
- 8.4.8.1. Spain: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.8.2. Spain.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.8.3. Spain: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.9. Genetic Toxicology Testing Market - Netherlands
- 8.4.9.1. Netherlands: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.9.2. Netherlands.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.9.3. Netherlands: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.10. Genetic Toxicology Testing Market - Russia
- 8.4.10.1. Russia: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.10.2. Russia.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.4.10.3. Russia: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.5. Genetic Toxicology Testing Market - Asia Pacific
- 8.5.1. Asia Pacific: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.2. Asia Pacific.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.3. Asia Pacific: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.4. Genetic Toxicology Testing Market - China
- 8.5.4.1. China: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.4.2. China.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.4.3. China: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.5. Genetic Toxicology Testing Market - India
- 8.5.5.1. India: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.5.2. India.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.5.3. India: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.6. Genetic Toxicology Testing Market - Malaysia
- 8.5.6.1. Malaysia: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.6.2. Malaysia.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.6.3. Malaysia: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.7. Genetic Toxicology Testing Market - Japan
- 8.5.7.1. Japan: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.7.2. Japan.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.7.3. Japan: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.8. Genetic Toxicology Testing Market - Indonesia
- 8.5.8.1. Indonesia: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.8.2. Indonesia.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.8.3. Indonesia: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.9. Genetic Toxicology Testing Market - South Korea
- 8.5.9.1. South Korea: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.9.2. South Korea.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.5.9.3. South Korea: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.6. Genetic Toxicology Testing Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.2. Middle East & Africa.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.3. Middle East & Africa: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.4. Genetic Toxicology Testing Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.4.3. Saudi Arabia: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.5. Genetic Toxicology Testing Market - UAE
- 8.6.5.1. UAE: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.5.2. UAE.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.5.3. UAE: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.6. Genetic Toxicology Testing Market - Israel
- 8.6.6.1. Israel: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.6.2. Israel.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.6.3. Israel: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.7. Genetic Toxicology Testing Market - South Africa
- 8.6.7.1. South Africa: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.7.2. South Africa.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.6.7.3. South Africa: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.7. Genetic Toxicology Testing Market - Latin America
- 8.7.1. Latin America: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.2. Latin America.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.7.3. Latin America: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.4. Genetic Toxicology Testing Market - Mexico
- 8.7.4.1. Mexico: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.4.2. Mexico.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.7.4.3. Mexico: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.5. Genetic Toxicology Testing Market - Brazil
- 8.7.5.1. Brazil: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.5.2. Brazil.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.7.5.3. Brazil: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.6. Genetic Toxicology Testing Market - Argentina
- 8.7.6.1. Argentina: Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.6.2. Argentina.: Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Billion)
- 8.7.6.3. Argentina: Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Thermo Fisher Scientific, Inc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Charles River Laboratories International
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Eurofins Scientific
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Merck KGAA
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Jubilant Life Sciences Ltd
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Laboratory Corp of America Holdings
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Gentronix Ltd
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Creative Bioarray
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. MB Research Laboratories
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Sotera Health LLC
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Environmental Bio-Detection Products Inc
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Cyprotex PLC
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Shanghai Medicilon Inc
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Toxikon Corporation
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Concave
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. BioReliance
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Fraunhofer ITEM
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development
- 10.18. Instem
- 10.18.1. Company Overview
- 10.18.2. Financial Performance
- 10.18.3. Product Benchmarking
- 10.18.4. Recent Development
- 10.19. Gentronix Ltd
- 10.19.1. Company Overview
- 10.19.2. Financial Performance
- 10.19.3. Product Benchmarking
- 10.19.4. Recent Development
- 10.20. Toxikon Corporation
- 10.20.1. Company Overview
- 10.20.2. Financial Performance
- 10.20.3. Product Benchmarking
- 10.20.4. Recent Development